TNNT2 and coronary artery disorder: Catechin administration attenuated coronary heart disease (CHD) by normalizing serum biomarkers of cardiac injury (creatine kinase, CK‐MB, lactate dehydrogenase, and cTnT) and improving cardiac function parameters (LVEF and LVIDs)